Galenica expands its digital health services for patients with chronic illnesses
Galenica continues to drive forward integrated and networked healthcare in Switzerland by acquiring a 16% stake in AD Swiss Ltd., the e-health provider for FMH, Ärztekasse and HIN. With “BENECURA public”, AD Swiss is able to offer digitally supported treatment programmes for people with chronic illnesses. Through this acquisition, Galenica is thus expanding its product range and services for those with chronic illnesses, and strengthening its network to other stakeholders in the healthcare sector.
In Switzerland, around 2.7 million people are living with chronic conditions such as diabetes, and cardiovascular and respiratory diseases. In order to improve the medical care that chronically ill patients receive, six established organisations, all ideally connected within the Swiss healthcare system, have joined forces to form a network: Galenica, Ärztekasse, FMH, HIN, SWICA and Swiss Medical Network. The mutual aim of the network partners is to provide optimal care for chronically ill patients through a hybrid range of treatment options. “BENECURA public” and its app gives patients and service providers access to first-rate support during treatment. The app provides users with a wide range of digital services, such as the digital “SymptomCheck” tool, which was developed by doctors to offer individual treatment recommendations, “PreventionCheck” for preventive check-ups, “Ready for doctor” for independent preparation before doctor's visits, and a digital patient file, the "Health Dossier", that can be shared directly with the attending physician on request. In the future, the Galenica Group pharmacy formats will also be integrated into customer journeys, for example for specific consultations and medication purchases on-site, online or with an e-prescription.
In this way, Galenica and its network partners are contributing to improving patients' quality of life, making them active participants in their own care process and improving the options available to service providers.
Partners join forces under the AD Swiss umbrella
“BENECURA public” is provided by the e-health provider AD Swiss. In addition to the existing shareholders FMH, Ärztekasse and HIN, Galenica, AEVIS VICTORIA (main shareholder of Swiss Medical Network) and SWICA will now also invest in the further development of AD Swiss' services and take a seat on its Board of Directors. AD Swiss’ chronic care services consist of medical devices that are new to the Swiss healthcare system. The services are complementary to and compatible with existing digital health projects such as platforms, ecosystems and the electronic patient record. The trustees of AD Swiss consider cooperation with additional partners to be crucial for sustainable progress within Swiss healthcare, as well as the long-term success of digital health services. This is why “BENECURA public” is available to all stakeholders in the healthcare sector.
The parties have agreed not to disclose the purchase price of the shares.
Other press releases
Ad hoc announcement pursuant to Art. 53 LR, Tuesday, 8 August 2023
Ad hoc announcement pursuant to Art. 53 LR, Tuesday, 25 July 2023
Press release, Wednesday, 19 July 2023
Ad hoc announcement pursuant to Art. 53 LR, Thursday, 11 May 2023